<DOC>
	<DOCNO>NCT00040911</DOCNO>
	<brief_summary>RATIONALE : Electroacupuncture may help reduce prevent delay nausea vomit patient treated chemotherapy . PURPOSE : This randomized clinical trial study effectiveness electroacupuncture treat delay nausea vomit patient receive chemotherapy newly diagnose childhood sarcoma , neuroblastoma , nasopharyngeal cancer , germ cell tumor , Hodgkin lymphoma .</brief_summary>
	<brief_title>Electroacupuncture Treating Delayed Nausea Vomiting Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma , Neuroblastoma , Nasopharyngeal Cancer , Germ Cell Tumors , Hodgkin Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine efficacy electroacupuncture , term reduce acute delay chemotherapy-induced nausea , patient newly diagnose pediatric sarcoma , neuroblastoma , nasopharyngeal carcinoma , germ cell tumor . Secondary - Determine efficacy therapy , term reduce delay chemotherapy-induced emesis , patient . - Determine efficacy therapy , term alter salivary cortisol level fast serum glucose insulin level stress parameter , patient . - Determine efficacy therapy , term improve quality life , patient . - Determine efficacy therapy , term reduce acute nausea emesis , patient . OUTLINE : This multicenter , randomize , double-blind study . Patients stratify accord plan treatment cisplatin-based chemotherapy ( yes v ) gender . Patients randomize 1 2 arm . - Arm I : Patients undergo electroacupuncture specific acupuncture point arm legs 25 minute twice daily day 1 2 daily day 3-7 week 1 chemotherapy course 1 ( 9 acupuncture treatment total ) . - Arm II : Patients undergo electroacupuncture sham point arm legs arm I . Quality life assess baseline , day 1 8 treatment course , completion study . PROJECTED ACCRUAL : A total 65 patient ( approximately 32 per arm ) accrue study within 2.5-3 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose malignancy 1 follow type : Pediatric sarcoma Neuroblastoma Nasopharyngeal carcinoma Germ cell tumor Hodgkin lymphoma Meets 1 follow criterion : Eligible Children 's Oncology Group ( COG ) protocol sarcoma , neuroblastoma , germ cell tumor Eligible NCI Pediatric Oncology Branch ( POB ) protocol sarcoma Following COGapproved standard treatment regimen sarcoma , neuroblastoma , nasopharyngeal carcinoma , germ cell tumor Enrolled POB natural history protocol 98C0037 Planned treatment , accord COG POB protocol , include cisplatin and/or doxorubicincontaining regimen sarcoma , neuroblastoma , nasopharyngeal carcinoma , germ cell tumor , Hodgkin lymphoma OR either cyclophosphamide/ifosfamidedoxorubicincontaining cyclophosphamide/dactinomycincontaining regimen rhabdomyosarcoma No clinical radiographic sign spinal cord compression PATIENT CHARACTERISTICS : Age : 5 35 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Platelet count great 50,000/mm^3 ( transfusion independent ) No clot disorder , include hemophilia Hepatic : PT PTT normal ( within 10 % institution 's upper limit normal ) Renal : Not specify Other : Not pregnant No casting 1 extremities No condition would preclude access acupuncture point No cognitive impairment PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No prior systemic chemotherapy Endocrine therapy : More 4 week since prior glucocorticoid therapy No concurrent glucocorticoid therapy Radiotherapy : Not specify Surgery : Not specify Other : No prior acupuncture No concurrent anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>nausea vomit</keyword>
	<keyword>localize osteosarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>localize Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
	<keyword>stage I lymphoepithelioma nasopharynx</keyword>
	<keyword>stage I squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage II lymphoepithelioma nasopharynx</keyword>
	<keyword>stage II squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
</DOC>